Pharma Focus Asia

Aptuit Laurus's New Manufacturing Facility in India


Aptuit, Inc. (Greenwich, Connecticut) and Laurus Labs Limited (Hyderabad, India) have formed a joint venture, to bring their presence in the Indian pharmaceutical market through a Research and Development facility near Hyderabad, which has recently completed, and a drug-manufacturing centre which is under construction in Visakhapatnam and an informatics development and support group. The initial phase of the manufacturing plant is expected to complete by early 2008.


The manufacturing facility will be located at Jawaharlal Nehru Pharma City, Visakhapatnam. Over 2,100 acres, the Pharma City site will provide 34 acres of land for the creation of a Drug Substance manufacturing facility.


The facility includes a common effluent treatment plant, common hazardous waste management and marine outfall for discharge of treated effluents, logistics hub and chemical feedstock. The facility will have three general chemistry blocks and a containment facility for oncology products. The facility will be validated to US FDA standards. The initial phase will create stand-alone process R&D and scale-up capability, including a dedicated pilot plant, and flexible manufacturing blocks capable of producing kilo to multi-tonne quantities in over 120 vessels. It also includes dedicated production blocks for cytotoxic and corticosteroid compound production and leaves ample space for significant future expansion.

Specifications Table:

  • Company Name
  • Aptuit Laurus
  • Location
  • Visakhapatnam, India
  • Plant Type
  • Manufacturing facility
  • Date of Start
  • Not Available
  • Date of Completion
  • 2008
  • Estimated Investment
  • Not Available
  • Key players
  • Sponsors/Partners
  • Aptuit, Inc. and Laurus Labs Limited
magazine-slider-imageHexagon - Expert Insights WebinarMFA + MMA 20244th Annual Cleaning Validation 20242nd Annual Pharma Impurity Conclave 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference